Actively Recruiting
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Led by Perceive Biotherapeutics, Inc. · Updated on 2025-10-15
60
Participants Needed
11
Research Sites
245 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Phase 1 safety study of VOY-101 comprises of escalating dose Cohorts, followed by a Phase 2a.
CONDITIONS
Official Title
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Are 60 years of age or older at the time of consent
- Are willing and able to understand and provide written informed consent
- Are willing and able to return for scheduled treatment and follow-up examinations
- Are able to undergo ETDRS best-corrected visual acuity testing and ophthalmic imaging
- Have well-demarcated geographic atrophy secondary to age-related macular degeneration without macular neovascularization or history of it in both eyes
- Show no signs of non-exudative macular neovascularization
- Meet additional ocular and genotype criteria related to AMD risk
You will not qualify if you...
- Are women of childbearing potential who are pregnant or unwilling to use effective contraception during the study
- Have other systemic, ocular, or genetic conditions that exclude participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Retina Macula Institute of AZ
Scottsdale, Arizona, United States, 85255
Actively Recruiting
2
The Retina Partners
Encino, California, United States, 91436
Actively Recruiting
3
Retinal Consultants Medical Group
Sacramento, California, United States, 95825
Actively Recruiting
4
Retina Consultants San Diego
San Diego, California, United States, 92064
Actively Recruiting
5
Star Retina
Burleson, Texas, United States, 76028
Actively Recruiting
6
Retina Center of Texas
Southlake, Texas, United States, 76092
Actively Recruiting
7
University of Utah John A. Moran Eye Center
Salt Lake City, Utah, United States, 84132
Actively Recruiting
8
Sydney Retina Clinic and Day Surgery
Sydney, New South Wales, Australia, 2000
Active, Not Recruiting
9
Cerulea Clinical Trials
East Melbourne, Victoria, Australia, 3002
Active, Not Recruiting
10
Rambam Medical Center
Haifa, Israel
Actively Recruiting
11
Tel-Aviv Sourasky Medical Center, Ophthalmology Division
Tel Aviv, Israel, 64239
Actively Recruiting
Research Team
A
Anne Fung, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here